Danusia Dzierzbinski New CFO of Orbis International

VERITAS Vision System Is Introduced by Johnson & Johnson

The company will offer live demos of the new system in a wet lab at the Johnson & Johnson booth (#2813) this weekend at the 2021 American Society of Cataract and Refractive Surgery and American Society of Ophthalmic Administrators Annual Meeting.

GenesisCare Orders 27 Elekta Flexitron Treatment Devices

"GenesisCare continues to demonstrate its commitment to improving patient outcomes worldwide and Elekta is delighted to play a vital partnering role to achieve this mission," said Gustaf Salford, Elekta's President and CEO.

FoodMarble AIRE Shown to Exceed the Performance of ‘Gold Standard’ SIBO Testing in Clinical Trial

SIBO is a very common disorder where there are excessive bacteria present in the small intestine. The true prevalence of SIBO in the general population is largely unknown, with some studies estimating its occurrence in up to 15% of healthy individuals. It is also largely associated with many other common clinical conditions, including irritable bowel syndrome, where 40-80% of IBS patients have SIBO.

Orbis International today announced the appointment of Danusia Dzierzbinski as Chief Financial Officer. Orbis, a leading global non-governmental organization, has been a pioneer in the prevention and treatment of avoidable blindness for over 30 years. Dzierzbinski will join the organization’s Executive Leadership Team.

Dzierzbinski joins Orbis International from the International Rescue Committee, where she most recently served as Deputy Chief Financial Officer and oversaw the financial management operations for a $750 million annual budget, following serving as Controller from 2006 to 2016. Previously, she was the Associate Director for Financial Planning & Analysis and Acting Internal Audit Director at Save the Children US. She began her career at KPMG LLP in audit services, focusing on consumer goods and not-for-profit organizations.

“We are thrilled to welcome Danusia to the team,” said Bob Ranck, President & CEO of Orbis International. “Her expertise will enable us to continue our track record of fiscal responsibility that makes us well-positioned to support the growth of our global operations and best serve our goal of transforming lives through the prevention and treatment of avoidable blindness.”

In 2018, supporters generously gave over $246.7M to the organization. Nearly 93 cents of every dollar donated goes directly to increasing quality eye care and saving vision in the countries where Orbis works.

Dzierzbinski will assume the responsibilities of outgoing Chief Financial and Administrative Officer Thomas J. Hill, who retires at the end of August. Dzierzbinski’s appointment is effective September 16, 2019.

“Orbis is making a life-changing impact on the communities it serves, leveraging technology to reach more people, while leading with a clear strategic direction for the organization – that combination is what energizes me,” said Dzierzbinski. “I’m looking forward to contributing to Orbis’s work in fighting avoidable blindness, with a focus on providing the financial management and resources to achieve greater impact.”



Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.